Apyx Medical's Return on Invested Capital Insights
Benzinga Pro data, Apyx Medical (NASDAQ:APYX) reported Q1 sales of $12.49 million. Earnings fell to a loss of $5.97 million, resulting in a 196.92% decrease from last quarter.
Benzinga ·